组胺N-甲基转移酶的上调,心脏缩和心力衰竭
Jinyan Zhang1,2,3,4, Hao Jiang1,2,3,4,5, Liwei Liu1,2,3,4
1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, No. 1609 Xietu Road, District Xuhui, Shanghai, China.
European heart journal
|January 22, 2026
概括
组胺N-甲基转移酶 (HNMT) 通过破坏代谢-表观遗传通路,使心力衰竭 (HF) 恶化. 用阿莫迪亚奎因抑制HNMT显示出对HF的治疗前景,尿液N-甲基组胺可能作为生物标志物.
科学领域:
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 代谢途径 代谢途径
背景情况:
- 胰岛素信号在心力衰竭 (HF) 中至关重要.
- 基因组胺N-甲基转移酶 (HNMT) 是用于心脏中的基因组胺清除的主要酶.
- 人们对HNMT在HF病变发生中的作用还不太了解.
研究的目的:
- 为了研究HNMT介导的HF的代谢-表观遗传交叉.
- 评估针对高频的HNMT轴的治疗策略.
主要方法:
- 产生的心肌细胞特异性Hnmt-knockout和过度表达的小鼠模型.
- 使用横向大动脉收缩 (TAC) 和血管新生素II诱导的HF.
- 利用RNA测序,向代谢,并测量HF患者的尿液N-甲基希斯胺水平.
主要成果:
- 在HF患者和小鼠的心脏组织中,HNMT被上调.
- 尿中的N-甲基组胺水平与HF严重程度相关.
- 删除或抑制HNMT可以改善心脏功能障碍,而过度表达会使心脏功能障碍恶化.
- HNMT降低了S-adenosylmethionine (SAM),损害了EZH2功能,降低了Fzd2促进器中的H3K27me3,导致FZD2上调和WNT/CaMKII通路激活.
结论:
- 通过SAM/FZD2/CaMKII轴,HNMT会加剧HF的发生.
- 阿莫迪亚奎因是一种HNMT抑制剂,显示出对HF的治疗潜力.
- 尿中的N-甲基组胺是一种潜在的非侵入性HF生物标志物.
相关概念视频
01:29Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
01:22Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
01:22Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227